AMPH R&D to Revenue
Amphastar Pharmaceuticals Inc · R&D to Revenue
AMPH R&D to Revenue
Latest reported11.92%period ending
AMPH FY R&D/Revenue (26.23% → 11.92%)
Latest values, visible window
High-resolution chart · PNG
AMPH r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 11.9246% | |
| 10.098% | |
| 11.4434% | |
| 14.9846% | |
| 13.9188% | |
| 19.2167% | |
| 21.3592% | |
| 19.5353% | |
| 18.0764% | |
| 16.146% | |
| 14.7365% | |
| 13.507% | |
| 14.376% | |
| 15.2518% | |
| 26.2336% |